The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
114494574 11449457 4 F 201508 20160630 20150903 20160708 EXP CA-AMGEN-CANSP2015089436 AMGEN 52.00 YR A F Y 0.00000 20160708 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
114494574 11449457 1 PS ENBREL ETANERCEPT 1 Unknown UNK U 103795 UNKNOWN FORMULATION
114494574 11449457 2 SS HUMIRA ADALIMUMAB 1 Unknown 40 MG, UNK 0 40 MG
114494574 11449457 3 SS METHOTREXATE (METHOTREXATE SODIUM) METHOTREXATE SODIUM 1 Oral 25 MG, QWK 0 25 MG /wk
114494574 11449457 4 SS METHOTREXATE (METHOTREXATE SODIUM) METHOTREXATE SODIUM 1 Oral 2.5 MG, QWK,EVERY TUESDAY 5 TABLETS ONCE A WEEK 0 2.5 MG /wk
114494574 11449457 5 SS METHOTREXATE (METHOTREXATE SODIUM) METHOTREXATE SODIUM 1 Oral 2.5 MG, QWK, EVERY WEDNESDAY (5 TABLETS/WEEK) FOR 90 DAYS 0 2.5 MG /wk
114494574 11449457 6 SS LEFLUNOMIDE. LEFLUNOMIDE 1 Unknown UNK 0 TABLET
114494574 11449457 7 SS ACTEMRA TOCILIZUMAB 1 Unknown 4 MG/KG, UNK 0 4 MG/KG
114494574 11449457 8 SS IBUPROFEN. IBUPROFEN 1 Oral 600 MG, TID, FOR 60 DAYS 0 600 MG TABLET TID
114494574 11449457 9 SS IBUPROFEN. IBUPROFEN 1 0 TABLET
114494574 11449457 10 SS NAPROXEN. NAPROXEN 1 Oral 500 MG, BID, FOR 90 DAYS 0 500 MG TABLET BID
114494574 11449457 11 SS NAPROXEN. NAPROXEN 1 Oral 750 MG, BID, FOR 90 DAYS 0 750 MG TABLET BID
114494574 11449457 12 SS FOLIC ACID. FOLIC ACID 1 Oral 5 MG, QWK, EVERY WEDNESDAY FOR 90 DAYS 0 5 MG /wk
114494574 11449457 13 SS FOLIC ACID. FOLIC ACID 1 Oral 5 MG, QWK,EVERY FRIDAY FOR 90 DAYS 0 5 MG /wk
114494574 11449457 14 SS PARIET RABEPRAZOLE SODIUM 1 Oral 20 MG, QD, FOR 90 DAYS 0 20 MG TABLET QD
114494574 11449457 15 SS PARIET RABEPRAZOLE SODIUM 1 Oral 20 MG, QD, FOR 90 DAYS 0 20 MG TABLET QD
114494574 11449457 16 SS METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Oral 40 MG, UNK 0 40 MG INJECTION
114494574 11449457 17 SS NAPROSYN NAPROXEN 1 Oral 500 MG, QD, FOR 90 DAYS 0 500 MG TABLET QD
114494574 11449457 18 SS NAPROSYN NAPROXEN 1 Oral 500 MG, BID, FOR 90 DAYS 0 500 MG TABLET BID
114494574 11449457 19 SS RITUXAN RITUXIMAB 1 Unknown UNK 0
114494574 11449457 20 C RABEPRAZOLE SODIUM. RABEPRAZOLE SODIUM 1 Oral 20 MG, UNK 0 20 MG
114494574 11449457 21 C XELJANZ TOFACITINIB CITRATE 1 Oral 5 MG, BID 0 5 MG BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
114494574 11449457 1 Rheumatoid arthritis
114494574 11449457 2 Rheumatoid arthritis
114494574 11449457 3 Rheumatoid arthritis
114494574 11449457 6 Rheumatoid arthritis
114494574 11449457 7 Product used for unknown indication
114494574 11449457 8 Rheumatoid arthritis
114494574 11449457 9 Arthralgia
114494574 11449457 10 Product used for unknown indication
114494574 11449457 12 Product used for unknown indication
114494574 11449457 14 Product used for unknown indication
114494574 11449457 16 Product used for unknown indication
114494574 11449457 17 Rheumatoid arthritis
114494574 11449457 19 Rheumatoid arthritis
114494574 11449457 21 Rheumatoid arthritis

Outcome of event

Event ID CASEID OUTC COD
114494574 11449457 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
114494574 11449457 Blood alkaline phosphatase increased
114494574 11449457 Condition aggravated
114494574 11449457 Drug hypersensitivity
114494574 11449457 Drug ineffective
114494574 11449457 Erythema
114494574 11449457 Joint swelling
114494574 11449457 Mouth ulceration
114494574 11449457 Nasal ulcer
114494574 11449457 Obesity
114494574 11449457 Pain
114494574 11449457 Rheumatoid arthritis
114494574 11449457 Stress
114494574 11449457 Swelling

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
114494574 11449457 2 201001 201008 0
114494574 11449457 3 200910 201205 0
114494574 11449457 4 20131015 0
114494574 11449457 5 20140613 0
114494574 11449457 6 200910 201302 0
114494574 11449457 7 201301 201310 0
114494574 11449457 8 20140514 0
114494574 11449457 10 20140613 0
114494574 11449457 11 20140925 0
114494574 11449457 12 20131015 0
114494574 11449457 13 20140613 0
114494574 11449457 14 20131015 0
114494574 11449457 15 20140613 0
114494574 11449457 16 20140409 0
114494574 11449457 17 20130702 0
114494574 11449457 18 20130702 0
114494574 11449457 21 20150907 0